Enterococcus and Its Association with Foodborne Illness

Total Page:16

File Type:pdf, Size:1020Kb

Enterococcus and Its Association with Foodborne Illness 6 Enterococcus and its Association with Foodborne Illness Simona F. Oprea and Marcus J. Zervos 1. INTRODUCTION Enterococci are an important group of bacteria and their interaction with humans is complex. On one hand, enterococci are part of the normal flora of humans and animals, and some of their strains are used for the manufacturing of foods or as probiotics, whereas others are known to cause serious diseases in humans. With the emergence of enterococci as the third most common cause of nosocomial blood-stream infections (1) as well as the alarming rise in enterococci resistance to multiple antimicrobials, more concentrated effort has been invested in the better understanding of this versatile microorganism. Although they are not classic foodborne pathogens, enterococci have earned their own place, in this book, as organisms that can be acquired from food. They have been associated with foodborne outbreaks because of their presence in foods and their capacity to carry and disseminate resistance genes through the food chain. The role of enterococci in disease raises concerns regarding their use in foods or as probiotics, whereas the imminent crisis of emergent antimicrobial resistance leads to measures that are urgently needed for the judicious use of antimicrobials in agriculture and human medicine. 2. CLASSIFICATION AND IDENTIFICATION Considered for a long time a major division of the genus Streptococcus, enterococci have undergone considerable changes in taxonomy in the last decades, including the recognition of Enterococcus as a separate genus in 1984 (2,3). Enterococci are catalase-negative Gram-positive cocci that occur singly, in pairs, or in short chains. They are facultative anaerobes and very tolerant to extreme temp- eratures, salinity, and pH; thus, they grow in 6.5% NaCl broth at pH 9.6 and at temperatures ranging from 10 to 45°C, with optimum growth at 35°C (2). Enterococci hydrolyze esculin in the presence of 40% bile-salts. Most enterococci hydrolyze L-pyrrolidonyl-G-naphtylamide (PYR) and all strains hydrolyze leucine-G-naphtylamide by producing leucine aminopeptidase (LAPase). Some species, such as E. gallinarum, are motile. From: Infectious Disease: Foodborne Diseases Edited by: S. Simjee © Humana Press Inc., Totowa, NJ 157 158 Oprea and Zervos Current criteria for the inclusion into the Enterococcus genus are a combination of DNA–DNA reassociation values, 16S rRNA gene sequencing, whole-cell protein analysis, and conventional phenotypic tests (2–4). Enterococci belong to the clostridial subdivision of Gram-positive bacteria, together with the other genera of lactic-acid bacteria: Aerococcus, Carnobacterium, Globicatella, Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, and Weissella (5). So far 23 distinct Enterococcus species have been recognized (3) but new species continue to be identified (6). They have been separated into five groups on the basis of acid formation in mannitol and sorbose broths, and hydrolysis of arginine (3). Group I consists of Enterococcus avium, Enterococcus malodoratus, Enterococcus raffinosus, Enterococcus pseudoavium, Enterococcus saccharolyticus, Enterococcus pallens, and Enterococcus gilvus. They form acid in both mannitol and sorbose broths but do not hydrolyze arginine. Group II consists of Enterococcus faecalis, Enterococcus faecium, Enterococcus casseliflavus, Enterococcus mundtii, and Enterococcus gallinarum. These five species form acid in mannitol but not sorbose broth and hydrolyze arginine. Group III includes Enterococcus durans, Enterococcus porcinus, Enterococcus ratti, Enterococcus hirae, Enterococcus dispar, and mannitol-negative variants of E. faecalis and E. faecium. The enterococci in Group IV do not produce acid in mannitol or sorbose broths and do not hydrolyze arginine. They are Enterococcus asini, Enterococcus sulfureus, and Enterococcus cecorum. Finally, Group V consists of the variant strains of Enterococcus casseliflavus, Enterococcus gallinarum, and Enterococcus faecalis that fail to hydrolyze arginine (3). Three new species of Enterococcus were recently identified from human clinical sources by the analysis of whole-cell protein profiles and DNA–DNA reassociation experiments, in conjunction with conventional physiological tests. These new enterococcal species, provisionally designated Enterococcus sp. nov. CDC PNS-E1, Enterococcus sp. nov. CDC PNS-E2, and Enterococcus sp. nov. CDC PNS-E3, resemble the physio- logical groups I, II and IV; two were isolated from human blood and one from human brain tissue. Resistance to vancomycin was detected in one of the strains, which is harboring the vanA resistance gene (6). The species most broadly distributed in nature are E. faecalis and E. faecium. Identification of the different Enterococcus species can be done by conventional physiological tests, by commercial systems, or by molecular methods. Correct species identification is important for appropriate antimicrobial treatment, for epidemiologic surveillance, and for the selection of starter strains and labeling of the product to which the starter is added. 3. RESERVOIRS Enterococci have the capacity to grow and survive in very harsh environments and thus occupy a variety of ecological niches. They can be found in soil, water, food, plants, animals (including mammals, birds, and insects), and humans. The major natural habitat of these organisms appears to be the gastrointestinal tract of humans and other animals were they make up a significant portion of the normal gut flora (4). With the increase in antimicrobial-resistant enterococci worldwide and their occasional implication in serious human diseases, there has been considerable interest in identifying the reservoirs of these organisms and of antimicrobial resistance genes. Enterococcus and Foodborne Illness 159 3.1. Nonhuman Reservoirs 3.1.1. In Mammals, Birds, and Insects Enterococci are a natural part of the intestinal flora in most mammals and birds. Insects and reptiles were also found to harbor these organisms. Some of the Enterococcus species are host-specific, while others are more broadly distributed. Exemples of host-specific enterococci are E. columbae, specific for pigeons, and E. asini, found so far only in donkeys. Several enterococcal species, although identifiable in a number of hosts, appear to have some host-specific properties (7). Few occasions, similar E. faecium strains have been found in animals and humans, and in some of these cases strains were epidemiologically related, originating from the farmer and one of his animals (7). Of importance, all of these studies were done on glycopeptide-resistant E. faecium. The most often encountered enterococcal species in the intestines of farm animals are E. faecalis, E. faecium, E. hirae, and E. durans. In chickens, E. faecalis, found early in life, is later replaced by E. faecium, and then by E. cecorum. Other species occasionally isolated from chickens are E. casseliflavus, E. gallinarum, and E. mundtii. 3.1.2. In Soil, Plants, and Water The presence of enterococci in these sources is usually a result of fecal contamination. E. faecium and E. faecalis have been the species most commonly recovered from water. E. casseliflavus, E. mundtii, and E. sulfureus appear to be plant-associated (7). 3.1.3. In Foods Enterococci are used as starter and probiotic cultures in foods, and they occur as natural food contaminants (8). They have been ascribed to both beneficial and detrimental roles in foods. In processed meats, enterococci can survive heat processing and cause spoilage, whereas in certain cheeses they contribute to ripening and development of flavor (5). Because of their heat-resistance, enterococci are often the only surviving bacte- rium (other than spore-formers) in heat-treated, semipreserved, nonsterile foods such as processed meats (9). Some enterococci produce bacteriocins (called enterocins) that exert anti-Listeria activity (5) and are also able to inhibit or kill other enterococci, clostridia, bacilli, and staphylococci. On the other hand, enterococci can cause food intoxication through the production of biogenic amines and can serve as a reservoir for virulence traits and antimicrobial resistance (10,11). E. faecalis and E. faecium, the strains most commonly associated with human infection, are also the strains most commonly found in foods or used as starter cultures. 3.1.4. Probiotics in Animal Feeds Enterococci are used as probiotics to improve the microbial balance of the intestine and to treat gastroenteritis in humans and animals (8). Their effects when used as pro- biotics are unclear, but studies have focused on growth-promoting of food animals and diminishing E. coli weaning diarrhea (7). The identification of common antimicrobial resistance determinants and antimicrobial resistant enterococcal isolates in humans, food, and food-producing animals, has led to concern about the safety of use of certain enterococcal strains as probiotics (5,12). 160 Oprea and Zervos 3.2. Human Reservoir Enterococci make up approx 1% of the normal intestinal flora of humans (13), being the predominant Gram-positive cocci in stool with concentrations ranging from 105 to 107 CFU/g in feces (14). E. faecalis is normally found in the stool of 90–100% of animals and humans, whereas E. faecium is found in 25%. Small num- bers of enterococci also occur in oropharyngeal secretions, the urogenital tract, and on the skin, especially in the perineal area (2,4). The prevalence of the different
Recommended publications
  • The Gut Microbiota of the Egyptian Mongoose As an Early Warning Indicator of Ecosystem Health in Portugal
    International Journal of Environmental Research and Public Health Article The Gut Microbiota of the Egyptian Mongoose as an Early Warning Indicator of Ecosystem Health in Portugal Mónica V. Cunha 1,2,3,* , Teresa Albuquerque 1, Patrícia Themudo 1, Carlos Fonseca 4, Victor Bandeira 4 and Luís M. Rosalino 2,4 1 National Institute for Agrarian and Veterinary Research (INIAV, IP), Wildlife, Hunting and Biodiversity R&D Unit, 2780-157 Oeiras, Portugal; [email protected] (T.A.); [email protected] (P.T.) 2 Centre for Ecology, Evolution and Environmental Changes (cE3c), Faculdade de Ciências da Universidade de Lisboa, 1749-016 Lisboa, Portugal; [email protected] 3 Biosystems & Integrative Sciences Institute (BioISI), Faculdade de Ciências da Universidade de Lisboa, 1749-016 Lisboa, Portugal 4 Departamento de Biologia & CESAM, Universidade de Aveiro, 3810-193 Aveiro, Portugal; [email protected] (C.F.); [email protected] (V.B.) * Correspondence: [email protected]; Tel.: +351-214-403-500 Received: 1 April 2020; Accepted: 27 April 2020; Published: 29 April 2020 Abstract: The Egyptian mongoose is a carnivore mammal species that in the last decades experienced a tremendous expansion in Iberia, particularly in Portugal, mainly due to its remarkable ecological plasticity in response to land-use changes. However, this species may have a disruptive role on native communities in areas where it has recently arrived due to predation and the potential introduction of novel pathogens. We report reference information on the cultivable gut microbial landscape of widely distributed Egyptian mongoose populations (Herpestes ichneumon, n = 53) and related antimicrobial tolerance across environmental gradients.
    [Show full text]
  • Current Trends of Enterococci in Dairy Products: a Comprehensive Review of Their Multiple Roles
    foods Review Current Trends of Enterococci in Dairy Products: A Comprehensive Review of Their Multiple Roles Maria de Lurdes Enes Dapkevicius 1,2,* , Bruna Sgardioli 1,2 , Sandra P. A. Câmara 1,2, Patrícia Poeta 3,4 and Francisco Xavier Malcata 5,6,* 1 Faculty of Agricultural and Environmental Sciences, University of the Azores, 9700-042 Angra do Heroísmo, Portugal; [email protected] (B.S.); [email protected] (S.P.A.C.) 2 Institute of Agricultural and Environmental Research and Technology (IITAA), University of the Azores, 9700-042 Angra do Heroísmo, Portugal 3 Microbiology and Antibiotic Resistance Team (MicroART), Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal; [email protected] 4 Associated Laboratory for Green Chemistry (LAQV-REQUIMTE), University NOVA of Lisboa, 2829-516 Lisboa, Portugal 5 LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 420-465 Porto, Portugal 6 FEUP—Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.d.L.E.D.); [email protected] (F.X.M.) Abstract: As a genus that has evolved for resistance against adverse environmental factors and that readily exchanges genetic elements, enterococci are well adapted to the cheese environment and may reach high numbers in artisanal cheeses. Their metabolites impact cheese flavor, texture, Citation: Dapkevicius, M.d.L.E.; and rheological properties, thus contributing to the development of its typical sensorial properties. Sgardioli, B.; Câmara, S.P.A.; Poeta, P.; Due to their antimicrobial activity, enterococci modulate the cheese microbiota, stimulate autoly- Malcata, F.X.
    [Show full text]
  • Diarrhea Caused by Enterococcus Villorum in Piglets
    JARQ 51 (3), 287 – 292 (2017) http://www.jircas.affrc.go.jp Diarrhea Caused by Enterococcus villorum in Piglets Diarrhea Caused by Enterococcus villorum in Piglets Yukiko TANIGUCHI1, Yukino TAMAMURA2, Yoshihiro WADA3, Ayumi KOBAYASHI4, Tomoyuki SHIBAHARA2, Yoshiharu ISHIKAWA5 and Koichi KADOTA5* 1 Tokachi Livestock Hygiene Service Center (Obihiro, Hokkaido 089-1182, Japan) 2 National Institute of Animal Health, National Agriculture and Food Research Organization (Tsukuba, Ibaraki 305-0856, Japan) 3 Ishikari Livestock Hygiene Service Center (Sapporo, Hokkaido 062-0045, Japan) 4 Shiribeshi Livestock Hygiene Service Center (Kutchan, Hokkaido 044-0083, Japan) 5 Hokkaido Research Station, National Institute of Animal Health, National Agriculture and Food Research Organization (Sapporo, Hokkaido 062-0045, Japan) Abstract Three of 10 piglets with watery diarrhea, aged 24, 21 and 22 days (cases 1, 2 and 3, respectively), were investigated in detail after euthanasia (as the remaining seven recovered without specific treatment). Enterococcal bacteria were isolated and multilocus sequence analysis showed 100% and 99% identity with the phenylalanyl tRNA synthase and RNA polymerase α subunit genes of strains of Enterococcus villorum, respectively. Histologically, severe epithelial desquamation, atrophy, and regeneration of ileal villi were observed in cases 1, 2 and 3, respectively. The number of bacteria was large in case 1, smaller in case 2, and sparse in case 3. These findings suggest that case 1 was at an earlier stage of enteropathy than case 2, and that case 3 was recovering. In case 1, the exfoliation of epithelial cells with many bacteria into the intestinal lumen was interpreted as a host reaction for eradicating marginally pathogenic enteroadherent bacteria.
    [Show full text]
  • Modulation of the Gut Microbiota Alters the Tumour-Suppressive Efficacy of Tim-3 Pathway Blockade in a Bacterial Species- and Host Factor-Dependent Manner
    microorganisms Article Modulation of the Gut Microbiota Alters the Tumour-Suppressive Efficacy of Tim-3 Pathway Blockade in a Bacterial Species- and Host Factor-Dependent Manner Bokyoung Lee 1,2, Jieun Lee 1,2, Min-Yeong Woo 1,2, Mi Jin Lee 1, Ho-Joon Shin 1,2, Kyongmin Kim 1,2 and Sun Park 1,2,* 1 Department of Microbiology, Ajou University School of Medicine, Youngtongku Wonchondong San 5, Suwon 442-749, Korea; [email protected] (B.L.); [email protected] (J.L.); [email protected] (M.-Y.W.); [email protected] (M.J.L.); [email protected] (H.-J.S.); [email protected] (K.K.) 2 Department of Biomedical Sciences, The Graduate School, Ajou University, Youngtongku Wonchondong San 5, Suwon 442-749, Korea * Correspondence: [email protected]; Tel.: +82-31-219-5070 Received: 22 August 2020; Accepted: 9 September 2020; Published: 11 September 2020 Abstract: T cell immunoglobulin and mucin domain-containing protein-3 (Tim-3) is an immune checkpoint molecule and a target for anti-cancer therapy. In this study, we examined whether gut microbiota manipulation altered the anti-tumour efficacy of Tim-3 blockade. The gut microbiota of mice was manipulated through the administration of antibiotics and oral gavage of bacteria. Alterations in the gut microbiome were analysed by 16S rRNA gene sequencing. Gut dysbiosis triggered by antibiotics attenuated the anti-tumour efficacy of Tim-3 blockade in both C57BL/6 and BALB/c mice. Anti-tumour efficacy was restored following oral gavage of faecal bacteria even as antibiotic administration continued. In the case of oral gavage of Enterococcus hirae or Lactobacillus johnsonii, transferred bacterial species and host mouse strain were critical determinants of the anti-tumour efficacy of Tim-3 blockade.
    [Show full text]
  • Mechanisms of Intrinsic Antibiotic Resistance in Enterococci Alexander Kiruthiga1,2, Kesavaram Padmavathy1*
    Review Article Mechanisms of intrinsic antibiotic resistance in enterococci Alexander Kiruthiga1,2, Kesavaram Padmavathy1* ABSTRACT Enterococci are considered as serious nosocomial pathogens as they are likely to exhibit resistance effectively to all antibiotics meant for clinical use. The most predominant species encountered frequently among human infections includes Enterococcus faecalis and Enterococcus faecium. Antibiotic resistance in enterococci may be either intrinsic or acquired through mutation of the intrinsic genes or horizontal gene transfer of resistance determinants. This paper reviews the mechanisms of intrinsic resistance in enterococci. KEY WORDS: Enterococcus faecalis, Enterococcus faecium, Enterococcus, Intrinsic resistance INTRODUCTION species and is not attributed to horizontal gene transfer.[4] The genes encoding intrinsic resistance Among Enterococci, Enterococcus faecalis and may either be expressed constitutively (always Enterococcus faecium are the most often encountered expressed) or induced (expressed only upon antibiotic species in various human infections ranging from exposure).[5] Due to the limited choice of antibiotics uncomplicated urinary tract infection to serious against enterococci, monotherapy with a single class bacteremia. Enterococci are considered as serious of antimicrobial agents often results in poor treatment nosocomial pathogens due to their intrinsic resistance outcomes and is significantly associated with and their potential to acquire resistance to various intrinsic resistance exhibited by them. Enterococci antimicrobial agents.[1] Besides exhibiting natural are proven to be intrinsically resistant to β-lactams, intrinsic resistance to multiple antimicrobial classes aminoglycosides, and sulfonamides.[6] (beta-lactams, aminoglycosides, and glycopeptides), they possess a remarkable ability to acquire resistance Intrinsic resistance in enterococci is found to be mediated to last resort of antibiotics (quinupristin-dalfopristin, by different mechanisms of resistance (Table 1).
    [Show full text]
  • Suppl Table 2
    Table S2. Large subunit rRNA gene sequences of Bacteria and Eukarya from V5. ["n" indicates information not specified in the NCBI GenBank database.] Accession number Q length Q start Q end e-value %-ident %-sim GI number Domain Phylum Family Genus / Species JQ997197 529 30 519 3E-165 89% 89% 48728139 Bacteria Actinobacteria Frankiaceae uncultured Frankia sp. JQ997198 732 17 128 2E-35 93% 93% 48728167 Bacteria Actinobacteria Frankiaceae uncultured Frankia sp. JQ997196 521 26 506 4E-95 81% 81% 48728178 Bacteria Actinobacteria Frankiaceae uncultured Frankia sp. JQ997274 369 8 54 4E-14 100% 100% 289551862 Bacteria Actinobacteria Mycobacteriaceae Mycobacterium abscessus JQ999637 486 5 321 7E-62 82% 82% 269314044 Bacteria Actinobacteria Mycobacteriaceae Mycobacterium immunoGenum JQ999638 554 17 509 0 92% 92% 44368 Bacteria Actinobacteria Mycobacteriaceae Mycobacterium kansasii JQ999639 552 18 455 0 93% 93% 196174916 Bacteria Actinobacteria Mycobacteriaceae Mycobacterium sHottsii JQ997284 598 5 598 0 90% 90% 2414571 Bacteria Actinobacteria Propionibacteriaceae Propionibacterium freudenreicHii JQ999640 567 14 560 8E-152 85% 85% 6714990 Bacteria Actinobacteria THermomonosporaceae Actinoallomurus spadix JQ997287 501 8 306 4E-119 93% 93% 5901576 Bacteria Actinobacteria THermomonosporaceae THermomonospora cHromoGena JQ999641 332 26 295 8E-115 95% 95% 291045144 Bacteria Actinobacteria Bifidobacteriaceae Bifidobacterium bifidum JQ999642 349 19 255 5E-82 90% 90% 30313593 Bacteria Bacteroidetes Bacteroidaceae Bacteroides caccae JQ997308 588 20 582 0 90%
    [Show full text]
  • Identification, Properties, and Application of Enterocins Produced by Enterococcal Isolates from Foods
    IDENTIFICATION, PROPERTIES, AND APPLICATION OF ENTEROCINS PRODUCED BY ENTEROCOCCAL ISOLATES FROM FOODS THESIS Presented in Partial Fulfillment of the Requirement for the Degree Master of Science in the Graduate School of The Ohio State University By Xueying Zhang, B.S. ***** The Ohio State University 2008 Master Committee: Approved by Professor Ahmed E. Yousef, Advisor Professor Hua Wang __________________________ Professor Luis Rodriguez-Saona Advisor Food Science and Nutrition ABSTRACT Bacteriocins produced by lactic acid bacteria have gained great attention because they have potentials for use as natural preservatives to improve food safety and stability. The objectives of the present study were to (1) screen foods and food products for lactic acid bacteria with antimicrobial activity against Gram-positive bacteria, (2) investigate virulence factors and antibiotic resistance among bacteriocin-producing enterooccal isolates, (3) characterize the antimicrobial agents and their structural gene, and (4) explore the feasibility of using these bacteriocins as food preservatives. In search for food-grade bacteriocin-producing bacteria that are active against spoilage and pathogenic microorganisms, various commercial food products were screened and fifty-one promising Gram-positive isolates were studied. Among them, fourteen food isolates with antimicrobial activity against food-borne pathogenic bacteria, Listeria monocytogenes and Bacillus cereus, were chosen for further study. Based on 16S ribosomal RNA gene sequence analysis, fourteen food isolates were identified as Enterococcus faecalis, and these enterococcal isolates were investigated for the presence of virulence factors and antibiotic resistance through genotypic and phenotypic screening. Results indicated that isolates encoded some combination of virulence factors. The esp gene, encoding extracellular surface protein, was not detected in any of the isolates.
    [Show full text]
  • Phage Infection Mediates Inhibition of Bystander Bacteria
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.11.077669; this version posted June 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Phage infection mediates inhibition of bystander bacteria 2 3 Anushila Chatterjeea*, Julia L. E. Willettb*, Gary M. Dunnyb, Breck A. Duerkopa,# 4 5 aDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, 6 CO, USA, 80045. bDepartment of Microbiology and Immunology, University of Minnesota Medical 7 School, Minneapolis, MN, USA, 55455. 8 9 #Correspondence: Breck A. Duerkop [email protected] 10 *A.C. and J.L.E.W. contributed equally to this work. 11 12 13 Running title: Phage induced T7SS promotes antibacterial antagonism 14 15 Key words: bacteriophages, Enterococcus, antibiotic resistance, phage–bacteria interactions, 16 bacterial secretion systems, type VII secretion, contact-dependent antagonism 17 18 19 20 21 22 23 24 25 26 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.05.11.077669; this version posted June 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 27 Abstract 28 Bacteriophages (phages) are being considered as alternative therapeutics for the treatment 29 of multidrug resistant bacterial infections.
    [Show full text]
  • ( 12 ) United States Patent
    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
    [Show full text]
  • Identification of Clinically Relevant Streptococcus and Enterococcus
    pathogens Article Identification of Clinically Relevant Streptococcus and Enterococcus Species Based on Biochemical Methods and 16S rRNA, sodA, tuf, rpoB, and recA Gene Sequencing Maja Kosecka-Strojek 1,* , Mariola Wolska 1, Dorota Zabicka˙ 2 , Ewa Sadowy 3 and Jacek Mi˛edzobrodzki 1 1 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] (M.W.); [email protected] (J.M.) 2 Department of Molecular Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] 3 Department of Epidemiology and Clinical Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-12-664-6365 Received: 13 October 2020; Accepted: 9 November 2020; Published: 11 November 2020 Abstract: Streptococci and enterococci are significant opportunistic pathogens in epidemiology and infectious medicine. High genetic and taxonomic similarities and several reclassifications within genera are the most challenging in species identification. The aim of this study was to identify Streptococcus and Enterococcus species using genetic and phenotypic methods and to determine the most discriminatory identification method. Thirty strains recovered from clinical samples representing 15 streptococcal species, five enterococcal species, and four nonstreptococcal species were subjected to bacterial identification by the Vitek® 2 system and Sanger-based sequencing methods targeting the 16S rRNA, sodA, tuf, rpoB, and recA genes. Phenotypic methods allowed the identification of 10 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains (Leuconostoc, Granulicatella, and Globicatella genera). The combination of sequencing methods allowed the identification of 21 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains.
    [Show full text]
  • The Ecology, Epidemiology and Virulence of Enterococcus
    Microbiology (2009), 155, 1749–1757 DOI 10.1099/mic.0.026385-0 Review The ecology, epidemiology and virulence of Enterococcus Katie Fisher and Carol Phillips Correspondence University of Northampton, School of Health, Park Campus, Boughton Green Road, Northampton Katie Fisher NN2 7AL, UK [email protected] Enterococci are Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic bacteria, which usually inhabit the alimentary tract of humans in addition to being isolated from environmental and animal sources. They are able to survive a range of stresses and hostile environments, including those of extreme temperature (5–65 6C), pH (4.5”10.0) and high NaCl concentration, enabling them to colonize a wide range of niches. Virulence factors of enterococci include the extracellular protein Esp and aggregation substances (Agg), both of which aid in colonization of the host. The nosocomial pathogenicity of enterococci has emerged in recent years, as well as increasing resistance to glycopeptide antibiotics. Understanding the ecology, epidemiology and virulence of Enterococcus speciesisimportant for limiting urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound infection, bacteraemia and neonatal sepsis, and also stemming the further development of antibiotic resistance. Introduction Taxonomy For many years Enterococcus species were believed to be The genus Enterococcus consists of Gram-positive, catalase- harmless to humans and considered unimportant med- negative, non-spore-forming, facultative anaerobic bacteria ically. Because they produce bacteriocins, Enterococcus that can occur both as single cocci and in chains. species have been used widely over the last decade in the Enterococci belong to a group of organisms known as food industry as probiotics or as starter cultures (Foulquie lactic acid bacteria (LAB) that produce bacteriocins Moreno et al., 2006).
    [Show full text]
  • Db20-0503.Full.Pdf
    Page 1 of 32 Diabetes Analysis of the Composition and Functions of the Microbiome in Diabetic Foot Osteomyelitis based on 16S rRNA and Metagenome Sequencing Technology Zou Mengchen1*; Cai Yulan2*; Hu Ping3*; Cao Yin1; Luo Xiangrong1; Fan Xinzhao1; Zhang Bao4; Wu Xianbo4; Jiang Nan5; Lin Qingrong5; Zhou Hao6; Xue Yaoming1; Gao Fang1# 1Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China 2Department of Endocrinology, Affiliated Hospital of Zunyi Medical College, Zunyi, China 3Department of Geriatric Medicine, Xiaogan Central Hospital, Xiaogan, China 4School of Public Health and Tropic Medicine, Southern Medical University, Guangzhou, China 5Department of Orthopaedics & Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China 6Department of Hospital Infection Management of Nanfang Hospital, Southern Medical University, Guangzhou, China *Zou mengchen, Cai yulan and Hu ping contributed equally to this work. Running title: Microbiome of Diabetic Foot Osteomyelitis Word count: 3915 Figures/Tables Count: 4Figures / 3 Tables References: 26 Diabetes Publish Ahead of Print, published online August 14, 2020 Diabetes Page 2 of 32 Keywords: diabetic foot osteomyelitis; microbiome; 16S rRNA sequencing; metagenome sequencing #Corresponding author: Gao Fang, E-mail: [email protected], Tel: 13006871226 Page 3 of 32 Diabetes ABSTRACT Metagenome sequencing has not been used in infected bone specimens. This study aimed to analyze the microbiome and its functions. This prospective observational study explored the microbiome and its functions of DFO (group DM) and posttraumatic foot osteomyelitis (PFO) (group NDM) based on 16S rRNA sequencing and metagenome sequencing technologies. Spearman analysis was used to explore the correlation between dominant species and clinical indicators of patients with DFO.
    [Show full text]